Novartis AG ADR annual revenue for fiscal TTM was $56.1 billion, an increase of 2.3% from $54.8 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $56.1B | $54.8B | $51.7B | $46.7B | $43.5B | $44.0B | $49.9B | $48.7B | $46.1B | $43.4B | $49.4B | $50.4B | $53.6B | $52.7B | $52.0B | $59.4B | $51.6B | $45.1B | $42.6B | $38.9B | $35.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $13.5B | $13.3B | $14.4B | $14.8B | $13.6B | $13.6B | $13.2B | $12.9B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NVS metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All NVS financial statements → Interactive NVS charts →
About TickerBase · Data methodology & sources